Abstract
Novel affinity-purified antibodies against human SGLT1 (hSGLT1) and SGLT2 (hSGLT2) were used to localize hSGLT2 in human kidney and hSGLT1 in human kidney, small intestine, liver, lung, and heart. The renal locations of both transporters largely resembled those in rats and mice; hSGLT2 and SGLT1 were localized to the brush border membrane (BBM) of proximal tubule S1/S2 and S3 segments, respectively. Different to rodents, the renal expression of hSGLT1 was absent in thick ascending limb of Henle (TALH) and macula densa, and the expression of both hSGLTs was sex-independent. In small intestinal enterocytes, hSGLT1 was localized to the BBM and subapical vesicles. Performing double labeling with glucagon-like peptide 1 (GLP-1) or glucose-dependent insulinotropic peptide (GIP), hSGLT1 was localized to GLP-1-secreting L cells and GIP-secreting K cells as has been shown in mice. In liver, hSGLT1 was localized to biliary duct cells as has been shown in rats. In lung, hSGLT1 was localized to alveolar epithelial type 2 cells and to bronchiolar Clara cells. Expression of hSGLT1 in Clara cells was verified by double labeling with the Clara cell secretory protein CC10. Double labeling of human heart with aquaporin 1 immunolocalized the hSGLT1 protein in heart capillaries rather than in previously assumed myocyte sarcolemma. The newly identified locations of hSGLT1 implicate several extra renal functions of this transporter, such as fluid absorption in the lung, energy supply to Clara cells, regulation of enteroendocrine cells secretion, and release of glucose from heart capillaries. These functions may be blocked by reversible SGLT1 inhibitors which are under development.
Similar content being viewed by others
References
Abdul-Ghani MA, DeFronzo RA, Norton L (2013) Novel hypothesis to explain why SGLT2 inhibitors inhibit only 30-50 % of filtered glucose load in humans. Diabetes 62:3324–3328
Balen D, Ljubojevic M, Breljak D, Brzica H, Zlender V, Koepsell H, Sabolic I (2008) Revised immunolocalization of the Na+-D-glucose cotransporter SGLT1 in rat organs with an improved antibody. Am J Physiol Cell Physiol 295:C475–C489
Banerjee SK, McGaffin KR, Pastor-Soler NM, Ahmad F (2009) SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states. Cardiovasc Res 84:111–118
Basset G, Crone C, Saumon G (1987) Fluid absorption by rat lung in situ: pathways for sodium entry in the luminal membrane of alveolar epithelium. J Physiol 384:325–345
Basset G, Saumon G, Bouchonnet F, Crone C (1988) Apical sodium-sugar transport in pulmonary epithelium in situ. Biochim Biophys Acta 942:11–18
Bodega F, Sironi C, Armilli M, Porta C, Agostoni E (2010) Evidence for Na+-glucose cotransporter in type I alveolar epithelium. Histochem Cell Biol 134:129–136
Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Chen J, Williams S, Ho S, Loraine H, Hagan D, Whaley JM, Feder JN (2010) Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members. Diabetes Ther 1:57–92
Crafer SM, Pryor JS, Dawson AP (1994) Effect of arterial-portal glucose gradients and phloridzin on bile glucose levels in perfused rat liver. J Physiol 479(Pt 2):281–289
Dahlin A, Royall J, Hohmann JG, Wang J (2009) Expression profiling of the solute carrier gene family in the mouse brain. J Pharmacol Exp Ther 329:558–570
Devaskar SU, deMello DE (1996) Cell-specific localization of glucose transporter proteins in mammalian lung. J Clin Endocrinol Metab 81:4373–4378
Diez-Sampedro A, Hirayama BA, Osswald C, Gorboulev V, Baumgarten K, Volk C, Wright EM, Koepsell H (2003) A glucose sensor hiding in a family of transporters. Proc Natl Acad Sci U S A 100:11753–11758
Elfeber K, Köhler A, Lutzenburg M, Osswald C, Galla HJ, Witte OW, Koepsell H (2004) Localization of the Na(+)-D-glucose cotransporter SGLT1 in the blood-brain barrier. Histochem Cell Biol 121:201–207
Elfeber K, Stümpel F, Gorboulev V, Mattig S, Deussen A, Kaissling B, Koepsell H (2004) Na+-D-glucose cotransporter in muscle capillaries increases glucose permeability. Biochem Biophys Res Commun 314:301–305
Evans CM, Williams OW, Tuvim MJ, Nigam R, Mixides GP, Blackburn MR, DeMayo FJ, Burns AR, Smith C, Reynolds SD, Stripp BR, Dickey BF (2004) Mucin is produced by clara cells in the proximal airways of antigen-challenged mice. Am J Respir Cell Mol Biol 31:382–394
Gorboulev V, Schürmann A, Vallon V, Kipp H, Jaschke A, Klessen D, Friedrich A, Scherneck S, Rieg T, Cunard R, Veyhl-Wichmann M, Srinivasan A, Balen D, Breljak D, Rexhepaj R, Parker HE, Gribble FM, Reimann F, Lang F, Wiese S, Sabolic I, Sendtner M, Koepsell H (2012) Na+-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes 61:187–196
Guzelian P, Boyer JL (1974) Glucose reabsorption from bile. Evidence for a biliohepatic circulation. J Clin Invest 53:526–535
Haase W, Heitmann K, Friese W, Ollig D, Koepsell H (1990) Characterization and histochemical localization of the rat intestinal Na+-D-glucose cotransporter by monoclonal antibodies. Eur J Cell Biol 52:297–309
Haase W, Koepsell H (1989) Electron microscopic immunohistochemical localization of components of Na+-cotransporters along the rat nephron. Eur J Cell Biol 48:360–374
Johnston CJ, Mango GW, Finkelstein JN, Stripp BR (1997) Altered pulmonary response to hyperoxia in Clara cell secretory protein deficient mice. Am J Respir Cell Mol Biol 17:147–155
Joris L, Quinton PM (1989) Evidence for electrogenic Na-glucose cotransport in tracheal epithelium. Pflugers Arch 415:118–120
Kanai Y, Lee W-S, You G, Brown D, Hediger MA (1994) The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose. J Clin Invest 93:397–404
Kemp PJ, Boyd CAR (1992) Pathways for glucose transport in type II pneumocytes freshly isolated from adult guinea pig lung. Am J Physiol Lung Cell Mol Physiol 263:L612–L616
Kipp H, Khoursandi S, Scharlau D, Kinne RKH (2003) More than apical: distribution of SGLT1 in Caco-2 cells. Am J Physiol Cell Physiol 285:C737–C749
Lazaridis KN, Pham L, Vroman B, de Groen PC, LaRusso NF (1997) Kinetic and molecular identification of sodium-dependent glucose transporter in normal rat cholangiocytes. Am J Physiol Gastrointest Liver Physiol 272:G1168–G1174
Lee W-S, Kanai Y, Wells RG, Hediger MA (1994) The high affinity Na+/glucose cotransporter. Re-evaluation of function and distribution of expression. J Biol Chem 269:12032–12039
Liakos A, Karagianis T, Athanasiadou E, Satigianni M, Mainou M, Paptheodorou K, Bekiari E, Tsapas A (2014) Efficacy and safety of empagliflozin for type 2 diabetes: a systematic review and meta-analysis. Diabetes Obes Metab 16:984–993
Liu JJ, Lee T, DeFronzo RA (2012) Why do SGLT2 inhibitors inhibit only 30–50 % of renal glucose reabsorption in humans? Diabetes 61:2199–2204
Macha S, Mattheus M, Halabi A, Pinnetti S, Woerle HJ, Broedl UC (2014) Pharmacokinetics, pharmacodynamics and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in subjects with renal impairment. Diabetes Obes Metab 16:215–222
Mamchaoui K, Makhloufi Y, Saumon G (2002) Glucose transporter gene expression in freshly isolated and cultured rat pneumocytes. Acta Physiol Scand 175:19–24
Masyuk AI, Masyuk TV, Tietz PS, Splinter PL, LaRusso NF (2002) Intrahepatic bile ducts transport water in response to absorbed glucose. Am J Physiol Cell Physiol 283:C785–C791
Neumiller JJ (2014) Empagliflozin: a new sodium-glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes. Drugs Context 3:212262, ISSN 1740-4398
Parker HE, Adriaenssens A, Rogers G, Richards P, Koepsell H, Reimann F, Gribble FM (2012) Predominant role of active versus facilitative glucose transport for glucagon-like peptide-1 secretion. Diabetologia 55:2445–2455
Parker HE, Habib AM, Rogers GJ, Gribble FM, Reimann F (2009) Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells. Diabetologia 52:289–298
Pezzulo AA, Gutierrez J, Duschner KS, McConnell KS, Taft PJ, Ernst SE, Yahr TL, Rahmouni K, Klesney-Tait J, Stoltz DA, Zabner J (2011) Glucose depletion in the airway surface liquid is essential for sterility of the airways. PLoS ONE 6:e16166
Poppe R, Karbach U, Gambaryan S, Wiesinger H, Lutzenburg M, Kraemer M, Witte OW, Koepsell H (1997) Expression of the Na+-D-glucose cotransporter SGLT1 in neurons. J Neurochem 69:84–94
Powell DR, Smith M, Greer J, Harris A, Zhao S, DaCosta C, Mseeh F, Shadoan MK, Sands A, Zambrowicz B, Ding ZM (2013) LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucose. J Pharmacol Exp Ther 345:250–259
Reimann F, Habib AM, Tolhurst G, Parker HE, Rogers GJ, Gribble FM (2008) Glucose sensing in L cells: a primary cell study. Cell Metab 8:532–539
Reynolds SD, Malkinson AM (2010) Clara cell: progenitor for the bronchiolar epithelium. Int J Biochem Cell Biol 42:1–4
Rutkovskiy A, Bliksoen M, Hillestad V, Amin M, Czibik G, Valen G, Vaage J, Amiry-Moghaddam M, Stenslokken KO (2013) Aquaporin-1 in cardiac endothelial cells is downregulated in ischemia, hypoxia and cardioplegia. J Mol Cell Cardiol 56:22–33
Rutkovskiy A, Valen G, Vaage J (2013) Cardiac aquaporins. Basic Res Cardiol 108:393
Sabolic I, Skarica M, Gorboulev V, Ljubojevic M, Balen D, Herak-Kramberger CM, Koepsell H (2006) Rat renal glucose transporter SGLT1 exhibits zonal distribution and androgen-dependent gender differences. Am J Physiol Ren Physiol 290:F913–F926
Sabolic I, Valenti G, Verbavatz J-M, Van Hoek AN, Verkman AS, Ausiello DA, Brown D (1992) Localization of the CHIP28 water channel in rat kidney. Am J Physiol 263(Cell Physiol 32):C1225–C1233
Sabolic I, Vrhovac I, Eror DB, Gerasimova M, Rose M, Breljak D, Ljubojevic M, Brzica H, Sebastiani A, Thal SC, Sauvant C, Kipp H, Vallon V, Koepsell H (2012) Expression of Na+-D-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences. Am J Physiol Cell Physiol 302:C1174–C1188
Shibazaki T, Tomae M, Ishikawa-Takemura Y, Fushimi N, Itoh F, Yamada M, Isaji M (2012) KGA-2727, a novel selective inhibitor of a high-affinity sodium glucose cotransporter (SGLT1), exhibits antidiabetic efficacy in rodent Models. J Pharmacol Exp Ther 342:288–296
Singh G, Katyal SL (1997) Clara cells and Clara cell 10 kD protein (CC10). Am J Respir Cell Mol Biol 17:141–143
Stripp BR, Reynolds SD (2008) Maintenance and repair of the bronchiolar epithelium. Proc Am Thorac Soc 5:328–333
Takata K, Kasahara T, Kasahara M, Ezaki O, Hirano H (1992) Immunohistochemical localization of Na+-dependent glucose transporter in rat jejunum. Cell Tissue Res 267:3–9
Thenappan T, Goel A, Marsboom G, Fang YH, Toth PT, Zhang HJ, Kajimoto H, Hong Z, Paul J, Wietholt C, Pogoriler J, Piao L, Rehman J, Archer SL (2011) A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion. Am J Respir Crit Care Med 183:1080–1091
Thomson SC, Rieg T, Miracle C, Mansoury H, Whaley J, Vallon V, Singh P (2012) Acute and chronic effects of SGLT2 blockage on glomerular and tubular function in the early diabetic rat. Am J Physiol Regul Integr Comp Physiol 302:R75–R83
Uldry M, Thorens B (2004) The SLC2 family of facilitated hexose and polyol transporters. Pflugers Arch-Eur J Physiol 447(5):480–489
Vallon V, Gerasimova M, Rose MA, Masuda T, Satriano J, Mayoux E, Koepsell H, Thomson SC, Rieg T (2014) SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice. Am J Physiol Ren Physiol 306:F194–F204
Vallon V, Platt KA, Cunard R, Schroth J, Whaley J, Thomson SC, Koepsell H, Rieg T (2010) SGLT2 mediates glucose reabsorption in the early proximal tubule. J Am Soc Nephrol 22:104–112
Veyhl M, Keller T, Gorboulev V, Vernaleken A, Koepsell H (2006) RS1(RSC1A1) regulates the exocytotic pathway of Na+-D-glucose cotransporter SGLT1. Am J Physiol Ren Physiol 291:F1213–F1223
von Lewinski D, Rainer PP, Gasser R, Huber M-S, Khafaga M, Wilhelm B, Haas T, Mächler H, Rössl U, Pieske B (2010) Glucose-transporter-mediated positive inotropic effects in human myocardium of diabetic and nondiabetic patients. Metabolism 59:1020–1028
Wright EM, Loo DDF, Hirayama BA (2011) Biology of human sodium glucose transporters. Physiol Rev 91:733–794
Yu AS, Hirayama BA, Timbol G, Liu J, Diez-Sampedro A, Kepe V, Satyamurthy N, Huang SC, Wright EM, Barrio JR (2013) Regional distribution of SGLT activity in rat brain in vivo. Am J Physiol Cell Physiol 304:C240–C247
Zambrowicz B, Freiman J, Brown PM, Frazier KS, Turnage A, Bronner J, Ruff D, Shadoan M, Banks P, Mseeh F, Rawlins DB, Goodwin NC, Mabon R, Harrison BA, Wilson A, Sands A, Powell DR (2012) LX4211, a dual SGLT1/SGLT2 inhibitor, improved glycemic control in patients with type 2 diabetes in a randomized, placebo-controlled trial. Clin Pharmacol Ther 92:158–169
Zhou L, Cryan EV, D’Andrea MR, Belkowski S, Conway BR, Demarest KT (2003) Human cardiomyocytes express high level of Na+/glucose cotransporter 1 (SGLT1). J Cell Biochem 90:339–346
Acknowledgments
The authors acknowledge the technical help by Mrs. Eva Heršak. This work was supported by the grant 022-0222148-2146 from Croatian Ministry for Science, Education and Sports (I.S.) and by Deutsche Forschungsgemeinschaft Grant KO 872/5-1 (H.K.).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Ivan Sabolić and Hermann Koepsell, both senior authors, contributed to this study with equal intellectual and organizational input.
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOC 5,864 kb)
Rights and permissions
About this article
Cite this article
Vrhovac, I., Balen Eror, D., Klessen, D. et al. Localizations of Na+-d-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart. Pflugers Arch - Eur J Physiol 467, 1881–1898 (2015). https://doi.org/10.1007/s00424-014-1619-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00424-014-1619-7